Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease.

albuminuria cardiorenal disease congestion congestive heart failure predictors

Journal

Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 30 12 2023
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and congestion in patients with congestive heart failure (CHF) remains somewhat scarce. This study aimed to evaluate the prevalence of albuminuria in a cohort of patients with CHF, identify the independent factors associated with albuminuria and analyse the correlation with different congestion parameters. This is a subanalysis of the Spanish Cardiorenal Registry, in which we enrolled 864 outpatients with heart failure and a value of urinary albumin:creatinine ratio (UACR) at the first visit. The median age was 74 years, 549 (63.5%) were male and 438 (50.7%) had a reduced left ventricular ejection fraction. A total of 350 patients (40.5%) had albuminuria. Among these patients, 386 (33.1%) had a UACR of 30-300 mg/g and 64 (7.4%) had a UACR >300 mg/g. In order of importance, the independent variables associated with higher UACR were estimated glomerular filtration rate determined by the Chronic Kidney Disease Epidemiology Collaboration equation ( In patients with chronic stable heart failure, the prevalence of albuminuria is high. The risk factors of albuminuria in this population are chronic kidney disease and hypertension. Congestion parameters are also associated with increased albuminuria.

Sections du résumé

Background UNASSIGNED
Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and congestion in patients with congestive heart failure (CHF) remains somewhat scarce. This study aimed to evaluate the prevalence of albuminuria in a cohort of patients with CHF, identify the independent factors associated with albuminuria and analyse the correlation with different congestion parameters.
Methods UNASSIGNED
This is a subanalysis of the Spanish Cardiorenal Registry, in which we enrolled 864 outpatients with heart failure and a value of urinary albumin:creatinine ratio (UACR) at the first visit.
Results UNASSIGNED
The median age was 74 years, 549 (63.5%) were male and 438 (50.7%) had a reduced left ventricular ejection fraction. A total of 350 patients (40.5%) had albuminuria. Among these patients, 386 (33.1%) had a UACR of 30-300 mg/g and 64 (7.4%) had a UACR >300 mg/g. In order of importance, the independent variables associated with higher UACR were estimated glomerular filtration rate determined by the Chronic Kidney Disease Epidemiology Collaboration equation (
Conclusions UNASSIGNED
In patients with chronic stable heart failure, the prevalence of albuminuria is high. The risk factors of albuminuria in this population are chronic kidney disease and hypertension. Congestion parameters are also associated with increased albuminuria.

Identifiants

pubmed: 38835512
doi: 10.1093/ckj/sfae140
pii: sfae140
pmc: PMC11145452
doi:

Types de publication

Journal Article

Langues

eng

Pagination

sfae140

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.

Déclaration de conflit d'intérêts

M.J.S. and J.N. are members of the CKJ editorial board.

Auteurs

Pau Llàcer (P)

Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain.

Marta Cobo Marcos (M)

Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid, Spain.

Rafael de la Espriella (R)

Department of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain.

Jara Gayán Ordás (J)

Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida, Lleida, Spain.

Isabel Zegri (I)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Aleix Fort (A)

Department of Cardiology, Hospital Universitari Dr Josep Trueta, Girona, Spain.

Adriana Rodríguez Chavarri (A)

Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.

Ana Méndez (A)

Department of Cardiology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Zorba Blázquez (Z)

Department of Cardiology, Hospital Universtiario Gregorio Marañón, Madrid, Spain.

Pedro Caravaca Pérez (P)

Department of Cardiology, Hospital Universitario Doce de Octubre, Madrid, Spain.

Jorge Rubio Gracia (J)

Department of Internal Medicine, Hospital Universitario Lozano Blesa, University of Zaragoza, Zaragoza, Spain.

Cristina Fernández (C)

Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain.

Alejandro Recio-Mayoral (A)

Department of Cardiology, Hospital Universitario Virgen Macarena, Sevilla, Spain.

Antonia Pomares (A)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Jose Manuel García Pinilla (JM)

Department of Cardiology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

Jorge Vazquez López-Ibor (J)

Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Almudena Castro (A)

Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.

Maria Jose Soler (MJ)

Department of Nephrology, Hospital Universitario Vall d´Hebron, Barcelona, Spain.

Jose Luis Górriz (JL)

Department of Nephrology, Hospital Clínico Universitario Valencia, University of Valencia, Valencia, Spain.

Ramón Bascompte Claret (R)

Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida, Lleida, Spain.

Paula Fluvià (P)

Department of Cardiology, Hospital Universitari Dr Josep Trueta, Girona, Spain.

Luis Manzano (L)

Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain.

Julio Núñez (J)

Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid, Spain.
Department of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain.

Classifications MeSH